Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Comparison of Biphasic Insulin Aspart Produced by the NN2000 Process to Current Process to in Type 2 Diabetes [Phase 3]
This Phase 3 trial update compares biphasic insulin aspart produced by the NN2000 process with the current production process in adults with…
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Effects of Dapagliflozin on Insulin Resistance and Insulin Secretion in Subjects With Type 2 Diabetes [Phase 2]
Phase 2 trial update reporting results on the effects of dapagliflozin on insulin resistance and insulin secretion in adults with Type 2 Dia…
-
FDA approval · 2017-03-01FDA Approved: FARXIGA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for Farxiga (dapagliflozin) from AstraZeneca Pharmaceuticals LP. This action updates the drug's …
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results [Phase 3]
A Phase 3 study evaluating liraglutide's effect and action in diabetes with cardiovascular outcomes results completed; results posted in 201…
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Metformin in Patients With Type 2 Diabetes [Phase 3]
An extension of a Phase 3 trial assessing the combination of vildagliptin with metformin for Type 2 diabetes has been updated; the study has…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Comparison of Three Liraglutide Formulations in Healthy Volunteers [Phase 1]
This Phase 1 trial compares three liraglutide formulations in healthy volunteers to assess pharmacokinetics and tolerability.
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Glimepiride in Patients With Type 2 Diabetes [Phase 3]
Extension to a Phase 3 study evaluating the efficacy and safety of vildagliptin in combination with glimepiride for type 2 diabetes mellitus…
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Safety of Inhaled Human Insulin in Subjects With Diabetes Mellitus and Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
Phase 3 trial evaluating inhaled human insulin in people with diabetes mellitus and chronic obstructive pulmonary disease has been terminate…
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Antidiabetic Effects on Intrahepatic Fat [Phase 4]
A Phase 4 clinical trial investigating antidiabetic effects on intrahepatic fat in patients with non-alcoholic fatty liver disease and type …
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Extension to a Study to Assess the Efficacy and Safety of Three Doses of Vildagliptin in Patients With Type 2 Diabetes [Phase 3]
This document provides an extension study update evaluating three doses of vildagliptin in patients with Type 2 diabetes mellitus, focusing …
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: A Multiple Dose Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0123-0000-0338 in Subjects With Type 2 Diabetes [Phase 1]
A completed Phase 1 multiple-dose trial evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of the diabetes drug candida…
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0148-0000-0287 in Healthy Subjects [Phase 1]
A Phase 1 trial evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of the experimental compound NNC0148-0000-0287 in…
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Extension to a Study of the Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes With Hemoglobin A1c (HbA1c) 9-11% [Phase 3]
Extension-phase completion update for a Phase 3 study evaluating the efficacy and safety of vildagliptin in patients with type 2 diabetes an…
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Efficacy and Safety of Inhaled Insulin Compared to Metformin and Glimepiride in Type 2 Diabetes [Phase 3]
A Phase 3 trial comparing inhaled insulin to metformin and glimepiride in type 2 diabetes was terminated; the update discusses the efficacy …
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Safety and Efficacy of Inhaled Insulin in Type 2 Diabetes [Phase 3]
A Phase 3 trial evaluating inhaled insulin for type 2 diabetes was terminated.
-
CLINICAL_TRIALS withdrawal · 2017-03-01Clinical Trial Update: The Effect of add-on Canagliflozin in Patients With Type 2 Diabetes Treated With U-500 Insulin [Phase 4]
A Phase 4 trial investigating add-on canagliflozin in Type 2 diabetes patients treated with U-500 insulin has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Efficacy and Safety of Inhaled Pre-prandial Human Insulin in Type 2 Diabetes [Phase 3]
A Phase 3 trial evaluating inhaled pre-prandial human insulin for Type 2 diabetes was terminated, with reported findings on efficacy and saf…
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Safety and Efficacy of Inhaled Pre-prandial Human Insulin in Type 2 Diabetes [Phase 3]
A Phase 3 clinical trial evaluating the safety and efficacy of inhaled prandial human insulin in Type 2 diabetes has been terminated. The sp…
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Efficacy of Near Infrared Phototherapy in Type 2 Diabetic Neuropathy [NA]
A clinical trial evaluating near-infrared phototherapy for type 2 diabetic neuropathy has been terminated; no efficacy results are provided …
-
CLINICAL_TRIALS trial_result · 2017-02-28Clinical Trial Update: Investigation on Safety, Tolerability, and Pharmacokinetics of Single Doses of NNC0113-0987 in Healthy Male Subjects [Phase 1]
Phase 1 study assessing safety, tolerability, and pharmacokinetics of single doses of NNC0113-0987 in healthy male volunteers; the trial has…
-
CLINICAL_TRIALS trial_result · 2017-02-28Clinical Trial Update: A Two Part Trial Investigating the Safety of NN9925 in Healthy Male Subjects [Phase 1]
A two-part Phase 1 trial evaluating the safety of NN9925 in healthy male subjects has completed, sponsored by Novo Nordisk A/S.
-
CLINICAL_TRIALS research · 2017-02-28Clinical Trial Update: Observational Study With InnoLet® in Daily Clinical Practice
Observational study evaluating the InnoLet insulin pen in daily clinical practice. The study has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-28Clinical Trial Update: Observational Study With Mixtard® 30 NovoLet® to Assess Patient Satisfaction
This is an observational trial update assessing patient satisfaction with Mixtard 30 NovoLet insulin in individuals with diabetes, with the …
-
CLINICAL_TRIALS trial_result · 2017-02-28Clinical Trial Update: Localisation of Potential Insulin Deposits in Normal Weight and Obese Diabetics Using 6 mm and 12 mm Long Needles [Phase 3]
Phase 3 trial sponsored by Novo Nordisk evaluated localization of potential insulin deposits using 6 mm and 12 mm long needles in adults wit…
-
CLINICAL_TRIALS trial_result · 2017-02-28Clinical Trial Update: NovoLet® Surveillance Study on Using Human Insulin System in Indonesia
This document reports the completion of a NovoLet surveillance trial in Indonesia evaluating the use of NovoLet (insulin human) for diabetes…